Alex brings more than 15 years of experience in rapidly growing data and analytics businesses. After heading up strategy and M&A for Thomson Reuters’ Life Sciences business, Alex oversaw the rapid growth at Evaluate, the leader in Life Sciences consensus forecasts.
Alex also acted as a board adviser to Scibite during its successful exit to Elsevier in 2020.